Since HSPGs are crucial for bone development, genetic defects in mucin-type O-glycan assembly would negatively impact HSPG presentation and function, thus contributing to skeletal and cartilage defects found across CDG disorders. This evidence concerns the gene SDC2 and congenital disorder of glycosylation.